Experimental Ebola vaccine could stop virus in West Africa
LONDON — An experimental vaccine tested on thousands of people in Guinea exposed to Ebola seems to work and might help shut down the ongoing epidemic in West Africa, according to interim results from a study published Friday.
There is currently no licensed treatment or vaccine for Ebola, which has so far killed more than 11,000 people since the world's biggest outbreak began last year.
If proven effective, the vaccine could be "a game-changer," said Dr. Margaret Chan, Director-General of the World Health Organization, which sponsored the trial.
In some 4,000 people who received the vaccine within 10 days of being identified as an Ebola contact, there were no cases of the disease. That compared with 16 cases in more than 3,500 people who only got the shot after 10 days.
Stories that may interest you
Israel's top Catholic prelate condemns police funeral attack
The top Catholic clergyman in the Holy Land says Israel's police attack on mourners during a funeral for an Al Jazeera journalist was a “severe” violation of human rights
Buttigieg sends $5B to cities for safety as road deaths soar
Upcoming data shows traffic deaths soaring in the U.S. The Biden administration is steering $5 billion in federal aid to cities and localities to address the growing crisis
Fewer nuggets, smaller salads: Shrinkflation hits U.S. restaurant diners
Feeling a bit cheated when you look down at your plate? It's not just a figment of your imagination - portions at U.S. restaurants are indeed getting smaller. Call it shrinkflation: when sizes shrink, but you're paying the same price, or sometimes even more, for the meal or product.
A civil war among neighbors over Confederate-themed streets
Mosby Woods, a quiet cluster of 523 homes in Fairfax City built in the mid-20th century, is a community that has grown divided over its identity as the City Council considers renaming its Confederate-named streets.
READER COMMENTS